metastatic carcinoma of stoamch

50
Metastatic Adenocarcinoma of Stomach

Upload: guruindia2012

Post on 07-May-2015

364 views

Category:

Health & Medicine


1 download

DESCRIPTION

histopathology ppt

TRANSCRIPT

Page 1: Metastatic carcinoma of stoamch

Metastatic Adenocarcinoma of Stomach

Page 2: Metastatic carcinoma of stoamch

• Adenocarcinoma of the Stomach

• Definition

• Malignant gland forming neoplasm of the stomach, exclusive of the EGJ and gastric cardia

Page 3: Metastatic carcinoma of stoamch

Gastric Cancer

Epidemiology

Forth common types of cancer

Second most common cancer related death

Geographic variations (ten times)

Continuing decline

Primarily a decline of distal GC

(2000) (2000)

Page 4: Metastatic carcinoma of stoamch

Geographic variations

Page 5: Metastatic carcinoma of stoamch

Gastric Cancer

Environmental factors

H. pylori Genetic factors

Etiological Factors of Gastric Cancer

Precancerous changes

Page 6: Metastatic carcinoma of stoamch

The role of H. Pylori infection in gastric carcinogensis

Type I carcinogen1994 by IARC

Gastric Cancer

Attributable risk50%~73%

Epidemiological studie

Page 7: Metastatic carcinoma of stoamch

Environmental factors

Environmental factors are involved

Japanese immigrants in US: 25%

Second generation: >50%

Subsequent generations: comparable to General US population

Page 8: Metastatic carcinoma of stoamch

Environmental factors

Lower socioeconomic status

Tobacco/alcohol

Fresh vegetable/fruits/Micronutrition

Poor food storage

Eating salted/Smoked food

Mucosal damage

Pro-carcinogen/Carcinogen

Lack of antioxidant

GASTRIC CANCERC

Page 9: Metastatic carcinoma of stoamch

Genetic factors

• The majority of gastric tumor are sporadic in nature

• There are rare inherited gastric cancer predisposition.

Page 10: Metastatic carcinoma of stoamch

Precancerous changes

Precancerous lesions

Precancerous conditions

Page 11: Metastatic carcinoma of stoamch

Precancerous lesions

• Defined as those pathological changes predisposed to

gastric cancer

dysplasia

• 10% of patients may progress in severity• majority of patients either regress or remain stable• High-grade dysplasia may be only a transient phase in the

progression to gastric cancer• occurs in atrophic gastritis or intestinal metaplasia

Page 12: Metastatic carcinoma of stoamch

Nature history of gastric dysplasia

No

Dysplasia

No

DysplasiaMild

Dysplasia

Mild

Dysplasia

Moderate

Dysplasia

Moderate

Dysplasia

High-grade

Dysplasia

High-grade

Dysplasia

Gastric

adenocarcinoma

Gastric

adenocarcinoma

5 years5 years 5 years5 years

5 years5 years

3 months-2 years3 months-2 years

10%10%

10%10%

50%-90%50%-90%

60%60%60%60%

10%10%

Page 13: Metastatic carcinoma of stoamch

Precancerous condition

• Defined as those clinical setting with higher risk of

developing gastric cancer

Chronic atrophic gastritis

Gastrectomy

Pernicious anemia

Menetrier’s disease

Chronic gastric ulcer

Gastric polyps

Page 14: Metastatic carcinoma of stoamch

Postulated sequence of histologic events in the progression to gastric adenocarcinoma and potential contributory factors

H. PyloriH. Pylori Other factorsOther factors

Chronic Superficial Gastritis

Chronic Superficial Gastritis

Intestinal Metaplasia

Intestinal Metaplasia

Atrophic Gastritis

Atrophic Gastritis DysplasiaDysplasia

FAP or Adenomas

FAP or Adenomas

Gastric Adenocarcinoma

Gastric Adenocarcinoma

Other factorsOther factors

AssociationAssociation Strong Association

Strong Association

Page 15: Metastatic carcinoma of stoamch

Pathology

Stages

Morphology

Pathohistologic classification

Metastasis

Page 16: Metastatic carcinoma of stoamch

Stages

• Early stage limited in the mucosa and sub mucosa layers, no matter with or without lymph node metastasis Classified by the Japanese Society for Gastric Cancer <1cm <0.5cm

• Advanced stage invaded over sub mucosa According to Bormann’ classification

Page 17: Metastatic carcinoma of stoamch

TNM classification (UICC)

0 Tis N0 M0 III A T2 N2 M0

I A T1 N0 M0 T3 N1 M0

I B T1 N1 M0 T4 N0 M0

T2 N0 M0 III B T3 N2 M0

II T1 N2 M0 IV T4 N2 M0

T2 N1 M0 T1~3 N3 M0

T3 N0 M0 any T any N M1

Page 18: Metastatic carcinoma of stoamch

Morphology---Early stage

Page 19: Metastatic carcinoma of stoamch

Morphology---Early stage

Page 20: Metastatic carcinoma of stoamch

Morphology---Early stage

Page 21: Metastatic carcinoma of stoamch

Morphology ---Advanced stage

Page 22: Metastatic carcinoma of stoamch

Histopathological classification

Histology

Adenocarcinoma 90%

Lymphoma 5%

Stromal 2%

Carcinoid <1%

Metastasis <1%

Adenosquamous/squamous <1%

Miscellaneous <1%

Page 23: Metastatic carcinoma of stoamch

Origin (Lauren)

• Intestinal type

associated with most environmental risk factors

carries a better prognosis

shows no familial history

• Diffuse type

consists of scattered cell clusters with poor prognosis

Page 24: Metastatic carcinoma of stoamch

Growth pattern (Ming)

• Expanding type

grew en mass and by expansion

resulting in the formation of discrete tumor nodules

with relatively good prognosis

• Infiltrative type

invaded individually

with poor prognosis

Page 25: Metastatic carcinoma of stoamch

Metastasis

Direct invasion

Lymph node dissemination

Blood spread

Intraperitoneal colonization

Page 26: Metastatic carcinoma of stoamch

Special term

• Blumer shelf

A shelf palpable by rectal examination, due to metastatic

tumor cells gravitating from an abdominal cancer and

growing in the rectovesical or rectouterine pouch

• Krukenberg tumor

A tumor in the ovary by the spread of stomach cancer

Page 27: Metastatic carcinoma of stoamch

Clinical manifestationSigns and Symptoms

Early Gastric Cancer

Asymptomatic or silent 80%

Peptic ulcer symptoms 10%

Nausea or vomiting 8%

Anorexia 8%

Early satiety 5%

Abdominal pain 2%

Gastrointestinal blood loss <2%

Weight loss <2%

Dysphagia <1%

Page 28: Metastatic carcinoma of stoamch

Signs and Symptoms

Advanced Gastric Cancer

Weight loss 60%

Abdominal pain 50%

Nausea or vomiting 30%

Anorexia 30%

Dysphagia 25%

Gastrointestinal blood loss 20%

Early satiety 20%

Peptic ulcer symptoms 20%

Abdominal mass or fullness 5%

Asymptomatic or silent <5%

Duration of symptoms

Less than 3 month 40%

3-12 months 40%

Longer than 12 month 20%

Page 29: Metastatic carcinoma of stoamch

Special signs & terms• Linitis plastica: diffusely infiltrating with a rigid stomach

• Virchow’s node: supraclavicular lymphadenopathy (left)

• Irish’s node: axillary lymphadenopathy

• Sister Mary Joseph’s node: umbilical lymphadenopathy

Page 30: Metastatic carcinoma of stoamch

Sister Mary Joseph’s node

Page 31: Metastatic carcinoma of stoamch

Laboratory tests

Iron deficiency anemia

Fecal occult blood test (FOBT)

Tumor markers (CEA, Ca19-9)

Page 32: Metastatic carcinoma of stoamch

Diagnosis

Endoscopic diagnosis

--- biopsy needed for definitive diagnosis

Radiologic diagnosis

Detection of early gastric cancer

Page 33: Metastatic carcinoma of stoamch

Endoscopic diagnosis

• In patients with signs and symptoms suggestive of

GC, and/or with compatible risk factors or paraneoplastic

conditions, the diagnostic procedure of choice could be

an endoscopic examination

• The diagnostic criteria for early or advanced gastric

cancer under endoscopy are based on the JRSGC and

Bormann’s classification

Page 34: Metastatic carcinoma of stoamch

Endoscopic features of gastric cancer

Page 35: Metastatic carcinoma of stoamch

Radiologic diagnosis • For reasons of cost and availability, radiography may sometimes be the first diagnostic procedure performed

• Classic radiography signs of malignant gastric ulcer

asymmetric/distorted ulcer crater

ulcer on the irregular mass

irregular/distorted mucosal folds

adjacent mucosa with obliterated /distorted area gastric

nodularity, mass effect, or loss of dispensability

Page 36: Metastatic carcinoma of stoamch

Radiologic diagnosis

Distal GC Proximal GC Linitis plastica

Page 37: Metastatic carcinoma of stoamch

Detection of early gastric cancer

• Endoscopic screening

general population or high risk persons

• Careful observation

Page 38: Metastatic carcinoma of stoamch

Differential diagnosis

Gastric Cancer

Gastric Ulcer

Page 39: Metastatic carcinoma of stoamch

Complications

• GI bleeding 5%

• Pylorus/cardia obstruction

• Perforation ulcer type

Page 40: Metastatic carcinoma of stoamch

Treatment

Surgical resection

EMR

Adjuvant therapy

Palliative therapy

Page 41: Metastatic carcinoma of stoamch

Endoscopic mucosal resection

Gastric cancer lesion confined to mucosa layer

Endoscopic ultrasound (EUS) is helpful in stageing GC

Page 42: Metastatic carcinoma of stoamch

Endoscopic mucosal resection

Page 43: Metastatic carcinoma of stoamch

Endoscopic mucosal resection

Page 44: Metastatic carcinoma of stoamch

Chemotherapy Regimen Approximate Survival

Response rate BenefitFluorouracil +doxorubicin 30% No

+ mitomycin (FAM)

Fluorouracil + doxorubicin 30% No

Semustine (FAMe)

Fluorouracil + doxorubicin 30% No

+ cisplatin (FAP)

Etoposide + doxorubicin 40% No

+ cisplatin (EAP)

Etoposide + leucovorin 30% No

+ fluorouracil (ELF)

Fluorouracil +doxorubicin 40% Unconfirmed

+ methotrexate (FAMTX)

Page 45: Metastatic carcinoma of stoamch

AIM OF COMBINATION THERAPYAIM OF COMBINATION THERAPY

INCREASED EFFICACYINCREASED EFFICACY

Different mechanisms of action Compatible side effects

Different mechanisms of resistance

ACTIVITYACTIVITY SAFETYSAFETY

Page 46: Metastatic carcinoma of stoamch

Side effects of chemotherapySide effects of chemotherapy

Mucositis

Nausea/vomiting

Diarrhea

Cystitis

Sterility

Myalgia

Neuropathy

Alopecia

Pulmonary fibrosis

Cardiotoxicity

Local reaction

Renal failure

Myelosuppression

Phlebitis

Page 47: Metastatic carcinoma of stoamch

Metal stent

Page 48: Metastatic carcinoma of stoamch

Prognosis

• The TNM classification/staging of gastric cancer is the best prognostic indicator

• The 5 years survival rate depends on the depth of gastric cancer invasion

• Patients in whom tumors are resectable for cure also have good prognosis

Page 49: Metastatic carcinoma of stoamch

Prevention

• Eradication of H. Pylori infection in those high risk

population family history of gastric cancer

chronic gastritis with apparent abnormality (atrophy, IM)

post early gastric cancer resection

gastric ulcer

• Management of dietary risk factor intake adequate amount of fruits, vegetables

minimize their intake of salty/smoked foods

Page 50: Metastatic carcinoma of stoamch

Prevention

• Tightly follow up those with precancerous condition

• Endoscopic or radiologic screening